Progression of autosomal-dominant polycystic kidney disease in children

G M Fick-Brosnahan1, Z V Tran, A M Johnson

  • 1Department of Medicine,University of Colorado Health Sciences Center, Denver, Colorado 80262, USA. godela.fick-brosnahan@uchsc.edu

Kidney International
|April 25, 2001
PubMed

Insights

Autosomal-dominant polycystic kidney disease (ADPKD) progression begins in childhood, marked by increased cyst number and kidney size. Children with early severe disease or high blood pressure show faster renal growth, identifying at-risk individuals for future therapies.

Area of Science:

  • Pediatric Nephrology
  • Genetics
  • Medical Research

Background:

  • Limited longitudinal data exists on childhood autosomal-dominant polycystic kidney disease (ADPKD) progression.
  • Previous studies focused on case reports, lacking large-scale analysis of natural disease course and risk factors in pediatric populations.
  • Understanding early ADPKD progression is crucial for timely intervention.

Purpose of the Study:

  • To conduct a longitudinal study on the natural progression of ADPKD in children.
  • To identify risk factors associated with more rapid renal enlargement in pediatric ADPKD patients.
  • To establish baseline data for evaluating future therapeutic interventions in children with ADPKD.

Main Methods:

  • Longitudinal study of 312 children from 131 families with ADPKD history since 1985.
  • Inclusion of physical examinations, biochemical tests, abdominal ultrasonography, and gene linkage analysis.
  • Repeated measurements of renal volumes via ultrasound over up to 15 years for 115 affected children.

Main Results:

  • Affected children exhibited significantly faster renal growth compared to unaffected peers.
  • Children with early severe ADPKD or hypertension demonstrated accelerated renal enlargement.
  • Glomerular filtration rate remained stable in most children, with declines only in two severe early-onset cases.

Conclusions:

  • ADPKD progression is evident in childhood, characterized by increased cyst formation and renal volume.
  • Early identification of rapid renal enlargement in children is possible.
  • This research highlights key indicators for children who may benefit most from emerging ADPKD therapies.
Abstract

Related Concept Videos

Nephrons01:10

Nephrons

The kidneys are intricate organs with millions of working units known as nephrons. Each nephron features two major structures: the renal corpuscle, which facilitates blood plasma filtration, and the renal tubule, which handles the glomerular filtrate. Blood supply is directly linked to the nephrons. The renal corpuscle consists of the glomerulus, a capillary network, and the Bowman's capsule, a double-walled epithelial structure that encases the glomerulus. The filtering of blood plasma happens...
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...